Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists

被引:11
|
作者
Cho, Kaimei [1 ]
Ando, Makoto [1 ]
Kobayashi, Kensuke [1 ]
Miyazoe, Hiroshi [1 ]
Tsujino, Toshiaki [1 ]
Ito, Sayaka [1 ]
Suzuki, Tomoki [1 ]
Tanaka, Takeshi [1 ]
Tokita, Shigeru [1 ]
Sato, Nagaaki [1 ]
机构
[1] Banyu Pharmaceut Co Ltd, Merck Res Labs, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan
关键词
NPY Y1 receptor antagonist; Cyclohexanamine; hERG K(+) channel; Serotonin transporter; SEROTONIN TRANSPORTER; PEPTIDE-YY; OBESITY; POTENT; NPYY1;
D O I
10.1016/j.bmcl.2009.06.050
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of cyclohexanamine derivatives was designed and synthesized as potent and selective human neuropeptide Y Y1 receptor antagonists. Modification of high-throughput screening hit compound 1 resulted in the identification of compound 3i, which displays potent Y1 activity and good selectivity towards hERG K(+) channel and serotonin transporter. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4781 / 4785
页数:5
相关论文
共 50 条
  • [1] Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists
    Hu, Shuanghua
    Huang, Yazhong
    Deshpande, Milind
    Luo, Guanglin
    Bruce, Marc A.
    Chen, Ling
    Mattson, Gail
    Iben, Lawrence G.
    Zhang, Jie
    Russell, John W.
    Clarke, Wendy J.
    Hogan, John B.
    Ortiz, Astrid
    Flint, Oliver
    Henwood, Andrew
    Gao, Qi
    Antal-Zimanyi, Ildiko
    Poindexter, Graham S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (03): : 222 - 226
  • [2] Synthesis and evaluation of substituted 4-alkoxy-2-aminopyridines as novel neuropeptide Y1 receptor antagonists
    Sato, N
    Shibata, T
    Jitsuoka, M
    Ohno, T
    Takahashi, T
    Hirohashi, T
    Kanno, T
    Iwaasa, H
    Kanatani, A
    Fukami, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) : 1761 - 1764
  • [3] Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists
    Zarrinmayeh, H
    Nunes, AM
    Ornstein, PL
    Zimmerman, DM
    Arnold, MB
    Schober, DA
    Gackenheimer, SL
    Bruns, RF
    Hipskind, PA
    Britton, TC
    Cantrell, BE
    Gehlert, DR
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) : 2709 - 2719
  • [4] Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists
    Griffith, David A.
    Hargrove, Diane M.
    Maurer, Tristan S.
    Blum, Charles A.
    De Lombaert, Stephane
    Inthavongsay, John K.
    Klade, Lee E.
    Mack, Christine M.
    Rose, Colin R.
    Sanders, Martin J.
    Carpino, Philip A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) : 2641 - 2645
  • [5] Neuropeptide Y and neuropeptide Y1 receptor expression in the rat retina
    D'Angelo, I
    Brecha, NC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S439 - S439
  • [6] Neuropeptide Y as a partial agonist of the Y1 receptor
    Sah, R
    Balasubramaniam, A
    Parker, MS
    Sallee, F
    Parker, SL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 525 (1-3) : 60 - 68
  • [7] Dental pulp fibroblasts express neuropeptide Y Y1 receptor but not neuropeptide Y
    Killough, S. A.
    Lundy, F. T.
    Irwin, C. R.
    INTERNATIONAL ENDODONTIC JOURNAL, 2010, 43 (10) : 835 - 842
  • [8] Neuropeptide Y Y1 receptor antagonism: a novel anabolic tool for bone regeneration
    Sousa, D. M.
    Baldock, P. A.
    Enriquez, R. E.
    Lamghari, M.
    Herzog, H.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2014, 8 : 81 - 82
  • [9] NEUROPEPTIDE-Y RECEPTOR SUBTYPES, Y1 AND Y2
    WAHLESTEDT, C
    GRUNDEMAR, L
    HAKANSON, R
    HEILIG, M
    SHEN, GH
    ZUKOWSKAGROJEC, Z
    REIS, DJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 611 : 7 - 26
  • [10] Design and discovery of neuropeptide Y-1 receptor antagonists
    Wright, J
    DRUG DISCOVERY TODAY, 1997, 2 (01) : 19 - 24